Rietiker elected as new chairman of tissue regen firm
This article was originally published in Clinica
BioCeramic Therapeutics (BCT), a London, UK-based company specialising in tissue regeneration, has elected Stephan Rietiker as its new chairman. Dr Rietiker takes over from Sir Richard Sykes, who will retire from the board. The change comes as Imperial College spin-off BCT prepares for the commercialisation of its first product in 2010. Dr Rietiker has been a non-executive director on BCT's board since December 2008. He has held various marketing and senior management positions in both pharma (Roche, Boehringer Mannheim and Schering Plough) and medtech (Centerpulse and IMI Intelligent Medical Implants) companies.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.